期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
The binding and structural basis of fox ACE2 to RBDs from different sarbecoviruses
1
作者 Junsen Chen Junqing Sun +8 位作者 Zepeng Xu Linjie Li Xinrui Kang Chunliang Luo Qi Wang Xueyang Guo Yan Li Kefang Liu Ying Wu 《Virologica Sinica》 SCIE CAS CSCD 2024年第4期609-618,共10页
Foxes are susceptible to SARS-CoV-2 in laboratory settings,and there have also been reports of natural infections of both SARS-CoV and SARS-CoV-2 in foxes.In this study,we assessed the binding capacities of fox ACE2 t... Foxes are susceptible to SARS-CoV-2 in laboratory settings,and there have also been reports of natural infections of both SARS-CoV and SARS-CoV-2 in foxes.In this study,we assessed the binding capacities of fox ACE2 to important sarbecoviruses,including SARS-CoV,SARS-CoV-2,and animal-origin SARS-CoV-2 related viruses.Our findings demonstrated that fox ACE2 exhibits broad binding capabilities to receptor-binding domains(RBDs)of sarbecoviruses.We further determined the cryo-EM structures of fox ACE2 complexed with RBDs of SARS-CoV,SARS-CoV-2 prototype(PT),and Omicron BF.7.Through structural analysis,we identified that the K417 mutation can weaken the ability of SARS-CoV-2 sub-variants to bind to fox ACE2,thereby reducing the susceptibility of foxes to SARS-CoV-2 sub-variants.In addition,the Y498 residue in the SARS-CoV RBD plays a crucial role in forming a vital cation-πinteraction with K353 in the fox ACE2 receptor.This interaction is the primary determinant for the higher affinity of the SARS-CoV RBD compared to that of the SARS-CoV-2 PT RBD.These results indicate that foxes serve as potential hosts for numerous sarbecoviruses,highlighting the critical importance of surveillance efforts. 展开更多
关键词 sarbecoviruses SARS-COV SARS-CoV-2 Fox ACE2 Omicron Cryo-EM structure
原文传递
Immunogenic relationship mapping supports a minimal-set trivalent vaccine strategy for broad sarbecovirus protection
2
作者 Yeqing Sun Ziqi Cheng +5 位作者 Xi Wu Yunbo Bai Lina Zhao Hongyu Xiang Weijin Huang Jianhui Nie 《Signal Transduction and Targeted Therapy》 2026年第3期1547-1555,共9页
Major outbreaks of severe acute respiratory syndrome(SARS)and coronavirus disease 2019(COVID-19),together with the continuous risk of zoonotic spillover of animal sarbecoviruses,underscore the urgent need for vaccines... Major outbreaks of severe acute respiratory syndrome(SARS)and coronavirus disease 2019(COVID-19),together with the continuous risk of zoonotic spillover of animal sarbecoviruses,underscore the urgent need for vaccines that confer broad protection across the sarbecovirus subgenus.Current immunogen selection strategies for pansarbecovirus vaccine development predominantly rely on phylogenetic or spike sequence conservation analyses,which often fail to accurately predict the breadth of cross-neutralization.To overcome this limitation,we systematically evaluated cross-neutralization profiles among 25 representative sarbecoviruses from clades 1 and 3 via guinea pig antisera individually raised against full-length spike proteins in pseudovirus neutralization assays while excluding clade 2 viruses lacking known receptor usage.Neutralization profiling revealed four distinct immunogenic clusters that diverged from traditional phylogenetic relationships.Antisera induced by the palm civet-derived SARS-CoV-1 strain SZ1 broadly neutralized all clade 1a viruses,whereas full coverage of clade 1b viruses required at least two distinct immunogens.Remarkably,sera elicited by multiple clade 1 immunogens also neutralized clade 3 viruses despite no prior exposure to clade 3 antigens.Guided by these findings,we proposed a minimal trivalent immunogen combination—SZ1,SARS-CoV-2,and PCoV-GX—that elicited broad neutralization against both clade 1 and clade 3.This rational approach eliminates the need for additional clade 3-specific antigens and provides a preclinical framework for developing next-generation pansarbecovirus vaccines. 展开更多
关键词 animal sarbecovirusesunderscore spike sequence conservation analyseswhich immunogen selection strategies sarbecovirus protection zoonotic spillover trivalent vaccine strategy coronavirus disease severe acute respiratory syndrome sars
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部